Schonfeld Strategic Advisors’s Sanaby Health Acquisition Corp. I Class A Common Stock SANB Stock Holding History

Schonfeld Strategic Advisors’s Portfolio SANB Stock Details SANB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,977	Closed	-$142K	–	3376
2022 Q3	$142K	Hold	13,977	–	–	﹤0.01%	2463
2022 Q2	$140K	Buy	13,977 +27	+0.2%	+$271	﹤0.01%	2046
2022 Q1	$140K	Buy	+13,950	New	+$139K	﹤0.01%	2126

Schonfeld Strategic Advisors's SANB Position: Q4 2022 in Review

Schonfeld Strategic Advisors sold out of Sanaby Health Acquisition Corp. I Class A Common Stock (SANB) in Q4 2022, closing a stake of 13,977 shares — an estimated $142K sold.

Schonfeld Strategic Advisors first reported a position in SANB in Q1 2022 and held it in 3 quarters. The position peaked at $142K in Q3 2022. 0 funds tracked by Wall St. Rank hold SANB as of Q4 2022.

Schonfeld Strategic Advisors reported no remaining Sanaby Health Acquisition Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Schonfeld Strategic Advisors sold 13,977 Sanaby Health Acquisition Corp. I Class A Common Stock shares in Q4 2022, an estimated $142K.
Schonfeld Strategic Advisors first reported a position in Sanaby Health Acquisition Corp. I Class A Common Stock in Q1 2022 and held it in 3 quarters.
Schonfeld Strategic Advisors's Sanaby Health Acquisition Corp. I Class A Common Stock position peaked at $142K in Q3 2022.
0 funds tracked by Wall St. Rank held Sanaby Health Acquisition Corp. I Class A Common Stock as of Q4 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.